HeartSciences (HSCS) Other financing activities (2022 - 2025)
HeartSciences (HSCS) posted quarterly Other financing activities of -$1.9 million for Q2 2025, down 10826.38% on a QoQ basis from $17250.0 in Q3 2022.
HeartSciences (HSCS) Other financing activities (2022 - 2025) Analysis & Trends
HeartSciences (HSCS) has reported Other financing activities for 2 consecutive years, with -$1.9 million the latest figure, recorded in Q2 2025.
- Quarterly Other financing activities changed N/A year-over-year to -$1.9 million in Q2 2025, while the trailing twelve-month figure through Apr 2025 was -$1.9 million (changed N/A YoY) and the FY2024 annual result came in at $334249.0, up 1837.68% from the prior year.
- Other financing activities declined to -$1.9 million in Q2 2025 per HSCS's latest filing, from $17250.0 in the prior quarter.
- Over the last five years, Other financing activities for HSCS reached as high as $17250.0 in Q3 2022 and fell as low as -$1.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | HeartSciences | 2.29 Mn | -1.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | -1.85 Mn |
| Apr 30, 2025 | -1.85 Mn |
| Jul 31, 2022 | 17,250.00 |
| Jul 31, 2022 | 17,250.00 |